Home Bistro Announces Record Revenue

This article is brought to you by Equifund Technologies, LLC.

Share on facebook
Share on twitter
Share on linkedin

On Feb 1, 2022, Home Bistro made an important announcement all investors – and potential investors – need to read…

First… they will be changing their fiscal year end from December 31st to October 31.

Why? According to management, this Oct – Oct reporting better matches the business cycle of its current business model.

This means we’re still waiting on Q4 financial results (which have traditionally been the best quarter of the year), but in the meantime…

The Company also reported record revenue of $1.64 million for the ten months ended October 31, 2021 compared to $1.34 million for the twelve months ended December 31, 2020.

Here are some highlights from 2021:

  • Transitioned away from shipping frozen meals to delivering fresh meals utilizing “Vacuum Skin Packaging” technology.
  • Added five celebrity chefs to its meal delivery platform.
  • Strategic acquisition of CA-based “Model Meals” lifestyle prepared meal delivery brand.
  • Relocated east coast operations to state-of-the-art South Florida-based food production and fulfillment facility, and now maintains bicoastal operations facilities (Orange County, CA).
  • Executed on partnerships with In Good Taste Wines (wine pairings), Perfecting Athletes (high performance meals), Red Velvet (desserts).
  • Launch of beta dessert menu item.

Commenting on the Company’s progress, Zalmi Duchman, Home Bistro’s CEO, said:

“Whereas 2020 was the launch year for our unique offering and competitive differentiation, 2021 was the year of execution.

Transitioning to fresh delivered meals was a game changer in terms of food quality, taste, experience and addressing consumer preferences.

We believe 2022 will be the year of significant organic growth and scalability as our platform continues to become more widely recognized. 

Further, we have identified several potential strategic acquisitions which could also add substantially to our revenue, product diversification and operationally efficiency.”

What’s their plan to continue to drive growth in 2022?

  • The continued addition of celebrity chefs to the platform and significant organic growth and scalability.
  • Launch of celebrity chef meals currently in development – Ayesha Curry, Priyanka Naik and Roblé Ali.
  • A potential strategic acquisition.
  • Launch of In Good Taste Wines and Perfecting Athletes initiatives, and the addition of several more dessert items.
  • Potential up-listing of Home Bistro shares to the Nasdaq Market.

Home Bistro is planning a shareholder update call to be scheduled in February. Details will be forthcoming in a future press release.

Considering an Investment in Home Bistro?

Home Bistro currently trades on the OTC Markets under the ticker symbol “HBIS”.

However, our Equifund members have access to their private Regulation A+ offering by going to this page right here. 

If you have any additional questions about this offering, be sure to use the Q&A form at the bottom of the offering page.

Your early-stage experts,


Like this article? Share it with a friend:

Share on facebook
Share on twitter
Share on linkedin

This article is not an Equifund Crowd Funding Portal Inc communication. It is brought to you by Equifund Technologies, LLC.

More Articles:

Don't make another private market investment without reading this...

The 5 Mistakes

investors make that crush returns

Download this free report now:

Just enter your name & email to access this report for free.

By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.

More Articles:


Kleiner Device Labs

Investment Highlights:

  • 1

    Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.

  • 2

    Over 20 patents have been issued to protect the company's technologies.

  • 3

    Just received FDA clearance for their next-generation KG2 spinal fusion technology.

Pre-Investment Agreement

The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO

Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:

    • Received and have reviewed the education materials sent to you.
    • UNDERSTAND; that there are restrictions on your ability to cancel your investment commitment and obtain a return of your investment.
    • KNOW; It may be difficult to resell securities acquired under Regulation Crowdfunding.
    • AGREE; investing in securities offered and sold in reliance on section 4(a)(6) of the Securities Act involves risk. Investors should not invest any funds unless he or she can afford to lose the entire amount of his or her investment. Your investment may not work out, and you must be in a financial condition to bear the loss.
  • Hidden
  • Hidden
  • Hidden
  • Hidden

We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.

Complete Your Registration

By verifying your account you agree with our terms of use, privacy policy and pre-dispute arbitration agreement. Please complete the registration process by clicking the link below:

Verify Your Email

Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.

If you have not received the email in 5 minutes, please click here to have it resent.

Questions? Our customer service team is always here to help – 1-866-338-3004

Enter your email address to get instant access to the video: